1-15 of 349
A Multidisciplinary Approach to Vulvar Lichen Sclerosus Care
DermConsultA Multidisciplinary Approach to Vulvar Lichen Sclerosus Care
Charles Turck, PharmD, BCPS, BCCCP
Christina Kraus, MD
Jill Krapf, MD
Heart Transplant in ATTR-CM: A New Look at Referral and Candidacy
On the Frontlines of ATTR-CMHeart Transplant in ATTR-CM: A New Look at Referral and Candidacy
Steve Jackson, PharmD
Alex Reyentovich, MD
Recognizing Telomere Biology Disorders in Familial Pulmonary Fibrosis
Clinician's RoundtableRecognizing Telomere Biology Disorders in Familial Pulmonary Fibrosis
Pilar Rivera-Ortega, MD
Precision Medicine in Fibrotic ILD: Predicting Risk and Treatment Response
Clinician's RoundtablePrecision Medicine in Fibrotic ILD: Predicting Risk and Treatment Response
Pilar Rivera-Ortega, MD
Targeting Pseudomonas aeruginosa in Bronchiectasis: Phase 2a Findings
Clinician's RoundtableTargeting Pseudomonas aeruginosa in Bronchiectasis: Phase 2a Findings
Colm Leonard, MD
Myeloid Mutations in ALL: Disease Risk and Prognostic Implications
Project Oncology®Myeloid Mutations in ALL: Disease Risk and Prognostic Implications
Caner Saygin, MD
- advertisement
Moving Beyond Chemotherapy in Mantle Cell Lymphoma Care
Project Oncology®Moving Beyond Chemotherapy in Mantle Cell Lymphoma Care
Jonathon Cohen, MD, MS
How Myeloid Mutations in ALL Inform Treatment Decisions
Project Oncology®How Myeloid Mutations in ALL Inform Treatment Decisions
Caner Saygin, MD
Key Questions Shaping Chemotherapy-Free Treatment in Mantle Cell Lymphoma
Project Oncology®Key Questions Shaping Chemotherapy-Free Treatment in Mantle Cell Lymphoma
Jonathon B. Cohen, MD, MS
Bruno Batinica, MD
Advancing ATTR-CM Identification: Early Findings from TRACE-AI
Heart MattersAdvancing ATTR-CM Identification: Early Findings from TRACE-AI
Bruno Batinica, MD
The Role of TTR Stabilization in ATTR-CM Treatment
On the Frontlines of ATTR-CMThe Role of TTR Stabilization in ATTR-CM Treatment
Steve Jackson, PharmD
Sumeet Mitter MD, MSc, FACC
- advertisement
Counseling Patients on Myelofibrosis Treatment Goals and Expectations
Project Oncology®Counseling Patients on Myelofibrosis Treatment Goals and Expectations
Shelina Ramnarine, PhD
John Mascarenhas, MD
Marina Kremyanskaya, MD
Recognizing Atypical Presentations of Inflammatory Dermatoses
DermConsultRecognizing Atypical Presentations of Inflammatory Dermatoses
Alexandria May, PharmD, BCPS
Naiem T. Issa, MD, PhD, FAAD
The Long Road to an FCS Diagnosis
On the Frontlines of Familial Chylomicronemia SyndromeThe Long Road to an FCS Diagnosis
Charles Turck, PharmD, BCPS, BCCCP
Peter P. Toth, MD, PhD, FAAFP, FICA, FAHA, FNLA, FCCP, FACC
